0 CHECKOUT

PRODUCT FILTERS

REGION

CATEGORIES

  • 13
  • 12
  • 10
  • 3
  • 3
  • 1
  • 1

PRICE

4
4
35
43

PUBLISHED

0
7
22
43

PRODUCT TYPE

39
3
1

Search for: "Idera Pharmaceuticals Inc-Therapeutic Competitors"

43 Products

Waldenstrom Macroglobulinemia - Pipeline Review, H2 2014

Waldenstrom Macroglobulinemia - Pipeline Review, H2 2014 Summary This, ‘Waldenstrom Macroglobulinemia - Pipeline Review, H2 2014’, provides an overview of the Waldenstrom Macroglobulinemia’s therapeutic...

Published:  September 2014
Price:  From

Waldenstrom Macroglobulinemia - Pipeline Review, H1 2014

Waldenstrom Macroglobulinemia - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Waldenstrom Macroglobulinemia - Pipeline Review, H1 2014’, provides an overview of the Waldenstrom Macroglobulinemia’s...

Published:  April 2014
Price:  From

Severe Psoriasis - Pipeline Review, H1 2014

Severe Psoriasis - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Severe Psoriasis - Pipeline Review, H1 2014’, provides an overview of the Severe Psoriasis’s therapeutic pipeline. This...

Published:  March 2014
Price:  From

Pulmonary Inflammation - Pipeline Review, H1 2014

Pulmonary Inflammation - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Pulmonary Inflammation - Pipeline Review, H1 2014’, provides an overview of the Pulmonary Inflammation’s therapeutic...

Published:  May 2014
Price:  From

Colitis - Pipeline Review, H1 2014

Colitis - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Colitis - Pipeline Review, H1 2014’, provides an overview of the Colitis’s therapeutic pipeline. This report provides comprehensive...

Published:  March 2014
Price:  From

Waldenstrom Macroglobulinemia - Pipeline Review, H1 2015

Waldenstrom Macroglobulinemia - Pipeline Review, H1 2015 Summary This, ‘Waldenstrom Macroglobulinemia - Pipeline Review, H1 2015’, provides an overview of the Waldenstrom Macroglobulinemia’s therapeutic...

Published:  April 2015
Price:  From

Diffuse Large B-Cell Lymphoma - Pipeline Review, H2 2014

Diffuse Large B-Cell Lymphoma - Pipeline Review, H2 2014 Summary This, ‘Diffuse Large B-Cell Lymphoma - Pipeline Review, H2 2014’, provides an overview of the Diffuse Large B-Cell Lymphoma’s therapeutic...

Published:  July 2014
Price:  From

Severe Psoriasis - Pipeline Review, H2 2014

Severe Psoriasis - Pipeline Review, H2 2014 Summary This, ‘Severe Psoriasis - Pipeline Review, H2 2014’, provides an overview of the Severe Psoriasis’s therapeutic pipeline. This report provides...

Published:  August 2014
Price:  From

Moderate Psoriasis - Pipeline Review, H1 2015

Moderate Psoriasis - Pipeline Review, H1 2015 Summary This, ‘Moderate Psoriasis - Pipeline Review, H1 2015’, provides an overview of the Moderate Psoriasis’s therapeutic pipeline. This report provides...

Published:  April 2015
Price:  From

Graft Versus Host Disease (GVHD) - Pipeline Review, H1 2015

Graft Versus Host Disease (GVHD) - Pipeline Review, H1 2015 Summary This, ‘Graft Versus Host Disease (GVHD) - Pipeline Review, H1 2015’, provides an overview of the Graft Versus Host Disease (GVHD)’s...

Published:  March 2015
Price:  From

Hyperlipidemia - Pipeline Review, H1 2014

Hyperlipidemia - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Hyperlipidemia - Pipeline Review, H1 2014’, provides an overview of the Hyperlipidemia’s therapeutic pipeline. This report...

Published:  April 2014
Price:  From

Duchenne Muscular Dystrophy - Pipeline Review, H1 2015

Duchenne Muscular Dystrophy - Pipeline Review, H1 2015 Summary This, ‘Duchenne Muscular Dystrophy - Pipeline Review, H1 2015’, provides an overview of the Duchenne Muscular Dystrophy’s therapeutic...

Published:  January 2015
Price:  From

Colon Cancer - Pipeline Review, H1 2015

Colon Cancer - Pipeline Review, H1 2015 Summary the, ‘Colon Cancer - Pipeline Review, H1 2015’, provides an overview of the Colon Cancer’s therapeutic pipeline. This report provides comprehensive...

Published:  June 2015
Price:  From

Graft Versus Host Disease (GVHD) - Pipeline Review, H2 2014

Graft Versus Host Disease (GVHD) - Pipeline Review, H2 2014 Summary This, ‘Graft Versus Host Disease (GVHD) - Pipeline Review, H2 2014’, provides an overview of the Graft Versus Host Disease (GVHD)’s...

Published:  September 2014
Price:  From

Rheumatoid Arthritis - Pipeline Review, H1 2014

Rheumatoid Arthritis - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Rheumatoid Arthritis - Pipeline Review, H1 2014’, provides an overview of the Rheumatoid Arthritis’s therapeutic pipeline. This...

Published:  February 2014
Price:  From

Severe Psoriasis - Pipeline Review, H1 2015

Severe Psoriasis - Pipeline Review, H1 2015 Summary This, ‘Severe Psoriasis - Pipeline Review, H1 2015’, provides an overview of the Severe Psoriasis’s therapeutic pipeline. This report provides...

Published:  April 2015
Price:  From

Moderate Psoriasis - Pipeline Review, H1 2014

Moderate Psoriasis - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Moderate Psoriasis - Pipeline Review, H1 2014’, provides an overview of the Moderate Psoriasis’s therapeutic pipeline. This...

Published:  March 2014
Price:  From

Systemic Lupus Erythematosus - Pipeline Review, H1 2014

Systemic Lupus Erythematosus - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Systemic Lupus Erythematosus - Pipeline Review, H1 2014’, provides an overview of the Systemic Lupus Erythematosus’s...

Published:  February 2014
Price:  From

Plaque Psoriasis (Psoriasis Vulgaris) - Pipeline Review, H1 2015

Plaque Psoriasis (Psoriasis Vulgaris) - Pipeline Review, H1 2015 Summary This, ‘Plaque Psoriasis (Psoriasis Vulgaris) - Pipeline Review, H1 2015’, provides an overview of the Plaque Psoriasis (Psoriasis...

Published:  May 2015
Price:  From

Multiple Sclerosis - Pipeline Review, H1 2015

Multiple Sclerosis - Pipeline Review, H1 2015 Summary the, ‘Multiple Sclerosis - Pipeline Review, H1 2015’, provides an overview of the Multiple Sclerosis’s therapeutic pipeline. This report provides...

Published:  June 2015
Price:  From
Loading Indicator

Our Clients

  • NBC Universal Inc.
  • Samsung Group Ltd.
  • E.ON SE
  • DHL International GmbH
  • University of Cambridge
  • Kone Oyj
  • BP Plc.